Lars Jørgen Østergaard
Oprichter bij iSD Immunotech ApS
Profiel
Lars Jørgen Østergaard is the founder and currently holds the position of Director at iSD Immunotech ApS, a company he founded in 2007.
He is also currently the Head of the Infectious Diseases Department and a Professor at Århus Universitetshospital.
Actieve functies van Lars Jørgen Østergaard
| Bedrijven | Functie | Begin |
|---|---|---|
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Oprichter | 08-09-2007 |
Århus Universitetshospital
 Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Århus Universitetshospital
Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Health Services |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
